In this episode, I move beyond “one crisis at a time” and look at geopolitics through the lens of a risk portfolio for pharma and med-tech supply chains.

Starting from recent events like Venezuela, the Red Sea, Taiwan, and Europe’s energy debate, I sketch a simple way to map exposure versus geopolitical fragility – not as a theoretical exercise, but as a practical tool for network and governance decisions.

I talk about what leaders can actually control: where buffers sit, how contracts handle sanctions and export controls, how decision rights are set, and which trade lanes are treated as “single points of failure.”

Using a concrete Latin America scenario, I walk through how a portfolio mindset changes the way you react to shocks, design options, and explain trade-offs to boards and regulators.

If you’re responsible for s ...